Synonyms:diflunisal, 22494-42-4, Dolobid, Dolobis, Fluniget, Flovacil, Fluodonil, Adomal, Flustar, 5-(2,4-Difluorophenyl)salicylic acid, 5-(2,4-difluorophenyl)-2-hydroxybenzoic acid, MK-647, Diflusinal, MK 647, 5-[2,4-Difluorophenyl]salicylic acid, 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid, 2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid, [1,1'-Biphenyl]-3-carboxylic acid, 2',4'-difluoro-4-hydroxy-, MFCD00057834, 5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID, 2',4'-difluoro-4-hydroxybiphenyl-3-carboxylic acid, 2',4'-Difluoro-4-hydroxy-(1,1'-biphenyl)-3-carboxylic acid, CHEMBL898, NSC-756728, (1,1'-Biphenyl)-3-carboxylic acid, 2',4'-difluoro-4-hydroxy-, MLS000028678, 7C546U4DEN, Algobid, Citidol, Difludol, DTXSID5022932, Noaldol, Reuflos, 2',4'-difluoro-4-hydroxy-[1,1'-biphenyl]-3-carboxylic acid, 2',4'-Difluoro-4-hydroxy[1,1'-biphenyl]-3-carboxylic acid, 3-BIPHENYLCARBOXYLIC ACID, 2',4'-DIFLUORO-4-HYDROXY-, CHEBI:39669, Unisal, 2',4'-difluoro-4-hydroxy-biphenyl-3-carboxylic acid, 1286107-99-0, NCGC00016765-01, Diflunisalum, Dolisal, Dolobil, SMR000058723, CAS-22494-42-4, Diflunisalum [INN-Latin], DTXCID702932, 1FL, Dolobid (TN), MK647, SR-01000003165, EINECS 245-034-9, BRN 2654431, UNII-7C546U4DEN, Diflunisal (JAN/USP/INN), Prestwick_168, Diflunisal [USAN:USP:INN:BAN:JAN], Spectrum_000962, DIFLUNISAL [MI], Opera_ID_803, DIFLUNISAL [INN], DIFLUNISAL [JAN], Prestwick0_000039, Prestwick1_000039, Prestwick2_000039, Prestwick3_000039, Spectrum2_001012, Spectrum3_000392, Spectrum4_000513, Spectrum5_000901, DIFLUNISAL [USAN], DIFLUNISAL [VANDF], DIFLUNISAL [MART.], SCHEMBL4337, DIFLUNISAL [USP-RS], DIFLUNISAL [WHO-DD], BSPBio_000137, BSPBio_002203, KBioGR_001085, KBioSS_001442, MLS001146895, BIDD:GT0063, DivK1c_000938, SPECTRUM1500245, SPBio_001163, SPBio_002058, Diflunisal, analytical standard, BPBio1_000151, GTPL7162, DIFLUNISAL [EP IMPURITY], DIFLUNISAL [ORANGE BOOK], HMS502O20, KBio1_000938, KBio2_001442, KBio2_004010, KBio2_006578, KBio3_001423, DIFLUNISAL [USP IMPURITY], NINDS_000938, DIFLUNISAL [USP MONOGRAPH], HMS1568G19, HMS1920G10, HMS2090C16, HMS2091M20, HMS2095G19, HMS3259G17, HMS3712G19, HMS3885H10, Pharmakon1600-01500245, BCP09905, Tox21_110598, BDBM50240510, CCG-40230, NSC756728, s4609, AKOS005762917, Tox21_110598_1, DB00861, KS-1346, NC00506, NSC 756728, IDI1_000938, NCGC00016765-02, NCGC00016765-03, NCGC00016765-04, NCGC00016765-05, NCGC00016765-06, NCGC00016765-08, NCGC00016765-09, NCGC00022783-03, NCGC00022783-04, HY-18342, SY106650, SBI-0051347.P003, DB-045934, AB00051969, CS-0007468, D5875, FT-0630487, C01691, D00130, AB00051969-12, AB00051969_13, EN300-3232727, A816230, 2',4'-difluoro-4-hydroxybipheny-3-carboxylic acid, J-014739, Q2602750, SR-01000003165-2, SR-01000003165-3, BRD-K22031190-001-05-3, BRD-K22031190-001-13-7, 5-(2,4-difluorophenyl)-2-hydroxy-benzoic acid;Diflunisal, Diflunisal, European Pharmacopoeia (EP) Reference Standard, 2',4'-Difluoro-4-hydroxy-(1',1-diphenyl)-3-carboxylic acid, Diflunisal, United States Pharmacopeia (USP) Reference Standard, 2 inverted exclamation mark ,4 inverted exclamation mark -Difluoro-4-hydroxybiphenyl-3-carboxylic Acid
Pubchem:PUBCHEM:3059
Id:bf7d1873-4f56-5eda-a7b0-3f839924d59e
Description:nan
